Startup profile for Sharpa: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Sharpa funding, valuation and investors

Full-stack Physical AI: 22-DoF dexterous hands, wheeled humanoids, and CraftNet manipulation models.

Keep track of Sharpa

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Growth (first public disclosure)

~$670M / >¥4.5B · August 2026

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

Not publicly disclosed

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

growth · Shanghai, China

Investors in latest funding

Other: Alibaba Group , Tencent , Meituan , JD.com , HongShan

Sources: latest funding Last verified: 2026-08-31

Overview

Sharpa is a Shanghai AI robotics company founded in late 2024 by Hesai Technology co-founders David Li Yifan, Xiang Shaoqing, and Sun Kai. Products include the Sharpa Wave (22-DoF tactile dexterous hand, mass production since October 2025), North wheeled humanoid robots, and CraftNet for dexterous manipulation. On August 28, 2026 secondary English coverage reported more than ¥4.5 billion (~$670 million) in financing at a reported ¥22 billion post-money, with Alibaba, Meituan, Tencent, JD.com, Transsion, HongShan, Qiming, Meituan DragonBall, and Luminous named. Company and press describe a fully automated Dairy Queen restaurant deployment and prior supply of dexterous hands into Nvidia Isaac GR00T reference humanoids (Unitree body). No Venture Capital Tracker /fund/ pages for named investors.

Why Sharpa is interesting

August 28, 2026: first public financing >¥4.5B (~$670M) at a reported ¥22B post, backed by Alibaba, Tencent, Meituan, JD, and HongShan. Hesai founders. Wave hands in mass production; Dairy Queen robot restaurant demo Aug 29 path.

Product & use cases

Dexterous manipulation stack: tactile hands, wheeled humanoids, and hierarchical VTLA models aimed at completing multi-step physical work without store retrofits.

  • Dexterous hands for humanoid OEMs and reference platforms
  • Retail / QSR automation without environmental modification
  • Industrial fine-manipulation tasks requiring contact-rich control

Key facts

  • Aug 28, 2026: >¥4.5B (~$670M) first public financing; ~¥22B post (reported)
  • Strategics: Alibaba, Tencent, Meituan, JD, Transsion
  • Wave 22-DoF hand in mass production since Oct 2025
  • DQ robot restaurant deployment reported Aug 29, 2026

Funding history (newest first)

Growth (first public disclosure)

2026-08 ~$670M / >¥4.5B
  • Alibaba Group (participant)
  • Tencent (participant)
  • Meituan (participant)
  • JD.com (participant)
  • HongShan (participant)

Source: https://yangtzeer.com/news/deals/sharpa-dexterous-robot-hands/

Competitive landscape

Edge: Founders’ Hesai public-company track record plus China platform strategic capital and live commercial restaurant demos — still early vs LinkerBot-class hand specialists on share.

  • LinkerBot direct

    Independent high-DoF dexterous-hand specialist; Yangtzeer cites large global share claims.

  • Unitree adjacent

    Robot OEM that has partnered on GR00T reference builds; also builds own hands.

Industries

Market / IPO context

Editorial / static context — not a live quote.

Related funding articles

Venture Capital Tracker pieces that cover Sharpa's financing or category context.

FAQs about Sharpa

Practical answers founders, operators, and investors typically search for.

More than ¥4.5 billion (~$670 million) reported August 28, 2026 as the first public financing disclosure.
Hesai Technology co-founders David Li Yifan, Xiang Shaoqing, and Sun Kai.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.